2008-09-18 |
Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia |
Cancer Letters. 2008 Sep 18;268(2):314-324. |
|
2008-06-11 |
治療癌症之醫藥組成物 |
I297606/2008-06-11 |
|
2008-02 |
A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells |
Anti-Cancer Drugs. 2008 Feb;19(2):151-158. |
|
2007-09-05 |
Propolin G, a prenylflavanone, isolated from Taiwanese propolis, induces caspase-dependent apoptosis in brain cancer cells |
Journal of Agricultural and Food Chemistry. 2007 Sep;55(18):7366-7376. |
|
2007-06-15 |
CTGF enhances the motility of breast cancer cells via an integrin-alpha v beta 3-ERK1/2-dependent S100A4-upregulated pathway |
Journal of Cell Science. 2007 Jun;120(12):2053-2065. |
|
2007-05 |
Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells - Implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome |
American Journal of Pathology. 2007 May;170(5):1607-1617. |
|
2007-04-15 |
Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL |
Cancer Research. 2007 Apr;67(8):3878-3887. |
|
2007-02-26 |
The role of the VEGF-C/VEGFR-3 axis in cancer progression |
British Journal of Cancer. 2007 Feb;96(4):541-545. |
|
2007-02-08 |
Isocostunolide, a sesquiterpene lactone, induces mitochondrial membrane depolarization and caspase-dependent apoptosis in human melanoma cells |
Cancer Letters. 2007 Feb;246(1-2):237-252. |
|
2006-03-01 |
Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone |
International Journal of Cancer. 2006 Mar;118(3):773-779. |
|
2006-02 |
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kappa B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa |
Journal of Endocrinology. 2006 Feb;188(2):311-319. |
|
2006-01-06 |
A pathway for tumor necrosis factor-alpha-induced Bcl10 nuclear translocation - Bcl10 is up-regulated by NF-kappaB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus |
Journal of Biological Chemistry. 2006 Jan;281(1):167-175. |
|
2005-11-01 |
Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome |
Blood. 2005 Nov;106(9):3090-3096. |
|
2005-10 |
Differentiation of pheochromocytoma PC12 cells induced by human urine extract and the involvement of the extracellular signal-regulated kinase signaling pathway |
Journal of Alternative and Complementary Medicine. 2005 Oct;11(5):903-908. |
|
2005-06-01 |
Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas |
Human Molecular Genetics. 2005 Jun;14(11):1465-1474. |
|
2004-07-01 |
Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells |
Prostate. 2004 Jul;60(2):120-129. |
|
2004-06-18 |
Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappa B activation by protein phosphatase 4-mediated NF-kappa B p65 Thr dephosphorylation |
Journal of Biological Chemistry. 2004 Jun;279(25):26143-26148. |
|
2004-04-29 |
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death |
Oncogene. 2004 Apr;23(20):3580-3588. |
|
2003-08-22 |
Hepatitis B virus X protein activates a survival signaling by linking Src to phosphatidylinositol 3-kinase |
Journal of Biological Chemistry. 2003 Aug;278(34):31807-31813. |
|
2003-07-01 |
Involvement of nuclear transcription factor-kappa B in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells |
Biochemical Pharmacology. 2003 Jul;66(1):25-33. |
|
2003-01 |
Epstein-Barr virus latent membrane protein-1 mediates upregulation of tumor necrosis factor-alpha in EBV-infected T cells: Implications for the pathogenesis of hemophagocytic syndrome |
Journal of Biomedical Science. 2003 Jan;10(1):146-155. |
|
2002-11 |
Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin |
Anticancer Research. 2002 Nov-Dec;22(6C):4065-4071. |
|
2002-11 |
Protection of drug-induced apoptosis by up-regulation of receptor tyrosine kinase Axl gene in Epstein-Barr virus transactivator LMP1-transfected cells |
Molecular Biology of the Cell. 2002 Nov;13:157A. |
|
2002-11 |
Human urine extract protects PC12 cells from serum-deprivation-induced apoptosis involving mitogen-activated protein (MAP) kinase pathway that leads to cell fates different from those induced by NGF |
Molecular Biology of the Cell. 2002 Nov;13:165A-166A. |
|
2002-05-01 |
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappa B (NF-kappa B), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells |
Biochemical Pharmacology. 2002 May;63(9):1709-1716. |
|
2002-04-15 |
Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation |
Biochemical Pharmacology. 2002 Apr;63(8):1423-1430. |
|
2001-11 |
Modulation of mitochondrial and NF-kappa B functions during human urine extract CDA-II induced apoptosis in human hepatocellular carcinoma cells |
Clinical Cancer Research. 2001 Nov;7(11):310. |
|
2001-11 |
Potentiation of CDA-2 induced differentiation and apoptosis by antioxidants and nutraceuticals (Cryptomonadales) |
Clinical Cancer Research. 2001 Nov;7(11):361. |
|
2001-11 |
Synergistic induction of HL 60 cell differentiation by CDA-2 and 1,25-dihydroxyvitamin D-3 |
Clinical Cancer Research. 2001 Nov;7(11):359. |
|
2001-06-22 |
Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin |
Biochemical and Biophysical Research Communications. 2001 Jun;284(4):880-886. |
|
2001-02-08 |
The involvement of PI3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interlenkin-6 |
Oncogene. 2001 Feb;20(6):677-685. |
|
2001-02 |
Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells |
Molecular Pharmacology. 2001 Feb;59(2):254-262. |
|
2000-12 |
Retinoic acid-induced apoptotic pathway in T-cell lymphoma: Identification of four groups of genes with differential biological functions |
Experimental Hematology. 2000 Dec;28(12):1441-1450. |
|
2000-11 |
Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats |
Food and Chemical Toxicology. 2000 Nov;38(11):991-995. |
|
2000-11 |
Differentiation induced by CDA-2 In xenografts is responsible for the antitumorigenesis of human hepatoma and renal cell carcinoma in SCID mice |
Clinical Cancer Research. 2000 Nov;6:113. |
|
2000-08-18 |
Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway |
Journal of Biological Chemistry. 2000 Aug;275(33):25858-25864. |
|
2000-02 |
Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis |
Carcinogenesis. 2000 Feb;21(2):331-335. |
|
1999-07 |
Identification of phosphate-regulated genes by differential expression in the UV-irradiated host system |
Journal of Microbiological Methods. 1999 Jul;37(1):93-96. |
|
1999-05 |
Suppression of apoptosis by Bcl-2 to enhance benzene metabolites-induced oxidative DNA damage and mutagenesis: A possible mechanism of carcinogenesis |
Molecular Pharmacology. 1999 May;55(5):894-901. |
|
1999-01-15 |
Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-Lapachone-induced apoptosis through an oxidation-dependent pathway |
Cancer Research. 1999 Jan;59(2):391-398. |
|
1998-05 |
Biotherapy and gene therapy of cancers |
臺灣醫學. 1998 May;2(3):321-327. |
|